Skip to main content

Table 3 Folic acid supplementation and risk of heart defects and neural tube defects

From: Initiation and duration of folic acid supplementation in preventing congenital malformations

Variants of folic acid supplementation

Risk of heart defects

Risk of neural tube defects

No. of malformations

No. of infants

Incidence, per 1000 infants (95% CI)

Adjusted odds ratio (95% CI)a

P value

No. of malformations

No. of infants

Incidence, per 10,000 infants (95% CI)

Adjusted odds ratio (95% CI)a

P value

Supplementation

 No

7

873

8.0 (2.1–13.9)

1.00

 

1

867

11.5 (1.1–34.2)

1.00

 

 Yes

60

15,656

3.8 (2.9–4.8)

0.47 (0.21–1.02)

0.056

11

15,607

7.0 (2.9–11.2)

0.64 (0.08–5.15)

0.68

Initiation

 No supplementation

7

873

8.0 (2.1–13.9)

1.00

 

1

867

11.5 (1.1–34.2)

1.00

 

 Earlier than 3 months before pregnancy

10

1769

5.7 (2.2–9.2)

0.80 (0.29–2.20)

0.66

1

1760

5.7 (1.0–16.8)

0.63 (0.03–11.69)

0.76

 Within 3 months before pregnancy

18

5039

3.6 (1.9–5.2)

0.49 (0.20–1.21)

0.12

7

5028

13.9 (3.6–24.2)

1.62 (0.18–14.26)

0.66

 After pregnancy

31

8598

3.6 (2.3–4.9)

0.45 (0.20–1.04)

0.061

3

8570

3.5 (1.0–12.0)

0.33 (0.03–3.22)

0.34

Duration

 No supplement

7

873

8.0 (2.1–13.9)

1.00

 

1

867

11.5 (1.1–34.2)

1.00

 

  ≤ 3 months

41

10,526

3.9 (2.7–5.1)

0.49 (0.22–1.10)

0.084

6

10,491

5.7 (1.1–10.3)

0.55 (0.07–4.69)

0.59

  > 3 months

18

4880

3.7 (2.0–5.4)

0.50 (0.20–1.24)

0.13

5

4867

10.0 (1.0–19.0)

1.05 (0.11–10.19)

0.97

  1. aAdjusted for region, maternal age, ethnicity, parity, conception mode, education level, family income, history of adverse pregnancy outcomes, medicine exposure, and early pregnancy conditions